APOLLOE4 Phase 3 study of oral ALZ-801/valiltramiprosate in APOE ε4/ε4 homozygotes with early Alzheimer's disease: Trial design and baseline characteristics.

Susan AbushakraAnton P PorsteinssonMarwan SabbaghDavid WatsonAidan PowerEarvin LiangEmer MacSweeneyMerce BoadaSusan FlintRosalind McLaineJ Patrick KesslakJohn A HeyMartin Tolar

Published in: Alzheimer's & dementia (New York, N. Y.) (2024)

ε4/ε4 AD subjects.

Keyphrases

cognitive decline
open label
phase iii
phase ii
study protocol
clinical trial
high fat diet
mild cognitive impairment
double blind
placebo controlled
randomized controlled trial
adipose tissue